23
total announcements
KRSNAA.NS · 15 min delayed
Krsnaa Diagnostics Limited
Krsnaa Diagnostics Limited has submitted a copy of newspaper publication regarding a corrigendum to the notice of postal ballot for a preferential issue of warrants.
Krsnaa Diagnostics Limited
Krsnaa Diagnostics Limited has issued a corrigendum to its notice of postal ballot, providing additional details as per the directions of the National Stock Exchange of India Limited. The corrigendum includes modifications to the explanatory statement regarding the preferential issue of share warrants.
Krsnaa Diagnostics Limited
Krsnaa Diagnostics Limited has informed the Exchange about receiving an Order dated 14th August, 2026 passed by the Assistant Commissioner of Income Tax, Central Circle 2(1), Pune, under Section 154 read with Section 143(3) of the Income Tax Act, 1961, for Assessment Year 2022-23. The Order rectifies the tax computation under Section 115BBE of the Income Tax Act, 1961 on the additions made in the original assessment order dated 31.03.2024, resulting in a differential/additional demand of Rs. 12,09,98,110/-.
Krsnaa Diagnostics Limited
Krsnaa Diagnostics Limited has informed the Exchange about a preferential issue of up to 16,21,000 Warrants for the total amount of Rs. 91,74,86,000, to be issued to Mr. Rajendra Mutha and Krsna Diagnostics (Mumbai) Private Limited.
Krsnaa Diagnostics Limited
Krsnaa Diagnostics Limited held an earnings conference call to discuss its unaudited financial results for the quarter ended June 30, 2026. The company reported a 22% year-over-year growth in revenue and a 12% growth in like-to-like projects. It also announced the award of a significant contract for 34 CT scans across Himachal Pradesh.
Krsnaa Diagnostics Limited
Krsnaa Diagnostics Limited has informed the Exchange about the submission of a newspaper advertisement for a notice of postal ballot regarding the issuance of 16,21,000 warrants convertible into equity shares on a preferential basis to the promoter and promoter group.
Krsnaa Diagnostics Limited
Krsnaa Diagnostics Limited has informed the Exchange about Shareholders meeting and submission of Notice of Postal Ballot for issuance of up to 16,21,000 Warrants Convertible into Equity Shares on a Preferential Basis to the Promoter and Promoter Group of the Company.
Krsnaa Diagnostics Limited
Krsnaa Diagnostics Limited has informed the Exchange about the publication of unaudited financial results for the quarter ended June 30, 2026, in newspapers and on the company's website.
Krsnaa Diagnostics Limited
Krsnaa Diagnostics Limited has informed the Exchange about the link of recording for the earnings call dated August 14, 2026, as per Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Krsnaa Diagnostics Limited
Krsnaa Diagnostics Limited has released its Q1 FY2026-27 results, showing a 22% revenue growth and 2% increase in the number of patients served, but a moderation in margins due to upfront fixed costs. The company has also expanded its network and retail business, with a focus on accessibility and affordability.
Krsnaa Diagnostics Limited
Krsnaa Diagnostics Limited has announced its Q1 FY2027 results, with revenue growing 22% YoY to ₹2,355 million, and the Rajasthan pathology network transitioning from implementation to operations, contributing ₹257 million of revenue in Q1. The company has also approved the issue of share warrants to the Promoter and Promoter Group, subject to applicable approvals and regulatory requirements.
Krsnaa Diagnostics Limited
Krsnaa Diagnostics Limited has informed the Exchange about General Updates, including the outcome of its Board Meeting held on August 13, 2026. The Board has approved unaudited financial results for the quarter ended June 30, 2026, and has recommended a final dividend of INR 2.00 per share for the financial year 2024-25. The company has also issued 16,21,000 share warrants to Mr. Rajendra Mutha and Krsna Diagnostics (Mumbai) Private Limited at an issue price to be determined in the future.
Krsnaa Diagnostics Limited
Krsnaa Diagnostics Limited has announced its unaudited consolidated financial results for the quarter ended June 30, 2026, along with the record date for the final dividend of INR 2.00 per share, which is September 18, 2026.
Krsnaa Diagnostics Limited
Krsnaa Diagnostics Limited has informed the Exchange about General Updates, including unaudited consolidated financial results for the quarter ended June 30, 2026, along with the Limited Review Reports as issued by the statutory auditors of the Company. The Board of Directors has discussed and approved the financial results, director’s report, and notice of the 16th AGM. The Company has also issued 16,21,000 share warrants to Mr. Rajendra Mutha and Krsna Diagnostics (Mumbai) Private Limited (Promoter and Promoter Group) at an issue price determined in future.
Krsnaa Diagnostics Limited
Krsnaa Diagnostics Limited has announced its unaudited consolidated financial results for the quarter ended June 30, 2026, along with the Limited Review Reports as issued by the statutory auditors of the Company. The Board of Directors has also approved the issuance of 16,21,000 share warrants to Mr. Rajendra Mutha and Krsna Diagnostics (Mumbai) Private Limited (Promoter and Promoter Group) at an issue price determined in future, which would be higher of the floor price as on the relevant date in the future as determined in accordance with the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018 or Rs. 565/-.
Krsnaa Diagnostics Limited
Krsnaa Diagnostics Limited has announced its unaudited consolidated financial results for the quarter ended June 30, 2026, with revenue from operations at INR 2,355.32 million and profit for the period at INR 165.51 million. The company has also declared a final dividend of INR 2.00 per share for the financial year 2024-25. Additionally, the Board of Directors has approved the issuance of 16,21,000 share warrants to Mr. Rajendra Mutha and Krsna Diagnostics (Mumbai) Private Limited at an issue price to be determined in the future.
Krsnaa Diagnostics Limited
Krsnaa Diagnostics Limited has informed the Exchange about Schedule of meet for Post Earnings Conference Call on August 14, 2026, to discuss financial results for the quarter ended June 30, 2026.
Krsnaa Diagnostics Limited
Krsnaa Diagnostics Limited has informed the Exchange about entering into a Public Private Partnership (PPP) Agreement with the Director Health Services, Health & Family Welfare Department, Government of Himachal Pradesh for setting up, operating, managing, maintaining and reporting of CT Scan Diagnostic Facilities at 34 Government Health Institutions across the State of Himachal Pradesh.
Krsnaa Diagnostics Limited
Krsnaa Diagnostics Limited has submitted a certificate under SEBI (Depositories and Participants) Regulations, 2018, confirming the details of securities dematerialized or rematerialized during the quarter ended June 30, 2026.
Krsnaa Diagnostics Limited
Krsnaa Diagnostics Limited has submitted the Exchange a copy Scrutinizer's report of Postal Ballot. The company has informed the Exchange regarding voting results. The Special Resolutions mentioned in the Postal Ballot Notice dated April 17, 2026 has been passed by the Members of the Company with requisite majority on July 04, 2026.